we present an interim report of an ongoing , single-blind study of the effectiveness and safety of bromocriptine mesylate ( parlodel ) in 15 patients , 14 of whom had severe idiopathic parkinson 's disease ( stages 4 and 5 on the hoehn and yahr scale ) .
C0546852
bromocriptine mesylate
C0030567
idiopathic parkinson 's disease